Dr Lal Pathlabs Ltd
Dr. Lal PathLabs is engaged in the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations.
- Market Cap ₹ 19,158 Cr.
- Current Price ₹ 2,299
- High / Low ₹ 2,460 / 1,180
- Stock P/E 94.4
- Book Value ₹ 139
- Dividend Yield 0.52 %
- ROCE 32.1 %
- ROE 22.4 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 30.45%
Cons
- Stock is trading at 16.57 times its book value
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
263 | 267 | 292 | 318 | 292 | 301 | 335 | 366 | 328 | 302 | 266 | 432 | |
206 | 203 | 217 | 231 | 227 | 235 | 240 | 257 | 246 | 244 | 218 | 305 | |
Operating Profit | 57 | 64 | 75 | 87 | 66 | 66 | 95 | 109 | 82 | 57 | 48 | 127 |
OPM % | 22% | 24% | 26% | 27% | 22% | 22% | 28% | 30% | 25% | 19% | 18% | 29% |
Other Income | 7 | 9 | 9 | 11 | 12 | 14 | 14 | 15 | 14 | 12 | 11 | 13 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 4 | 4 | 4 | 4 | 4 |
Depreciation | 8 | 11 | 9 | 9 | 10 | 10 | 16 | 18 | 19 | 20 | 18 | 20 |
Profit before tax | 56 | 62 | 75 | 88 | 68 | 69 | 89 | 102 | 73 | 45 | 38 | 117 |
Tax % | 35% | 35% | 34% | 35% | 32% | 32% | 34% | 21% | 25% | 28% | 25% | 25% |
Net Profit | 36 | 40 | 49 | 57 | 46 | 47 | 59 | 80 | 54 | 32 | 28 | 85 |
EPS in Rs | 4.36 | 4.80 | 5.93 | 6.83 | 5.50 | 5.65 | 7.06 | 9.66 | 6.49 | 3.90 | 3.41 | 10.23 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|
237 | 342 | 452 | 558 | 660 | 791 | 912 | 1,057 | 1,203 | 1,330 | 1,328 | |
181 | 256 | 354 | 419 | 504 | 582 | 675 | 793 | 910 | 987 | 1,012 | |
Operating Profit | 57 | 87 | 98 | 139 | 156 | 210 | 238 | 264 | 294 | 344 | 315 |
OPM % | 24% | 25% | 22% | 25% | 24% | 26% | 26% | 25% | 24% | 26% | 24% |
Other Income | 2 | 2 | 3 | 8 | 12 | 20 | 27 | 31 | 46 | 55 | 50 |
Interest | 1 | 3 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 15 | 16 |
Depreciation | 14 | 20 | 20 | 27 | 28 | 28 | 28 | 33 | 38 | 73 | 76 |
Profit before tax | 45 | 66 | 80 | 119 | 140 | 201 | 237 | 261 | 301 | 310 | 274 |
Tax % | 34% | 32% | 31% | 33% | 31% | 34% | 34% | 34% | 33% | 27% | |
Net Profit | 29 | 45 | 55 | 80 | 96 | 132 | 155 | 171 | 199 | 226 | 200 |
EPS in Rs | 858.49 | 1,333.04 | 1,643.22 | 148.27 | 17.51 | 15.99 | 18.61 | 20.49 | 23.90 | 27.11 | 24.03 |
Dividend Payout % | 19% | 19% | 9% | 7% | 9% | 15% | 16% | 22% | 25% | 44% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 15% |
3 Years: | 13% |
TTM: | 3% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 19% |
3 Years: | 13% |
TTM: | -13% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 25% |
3 Years: | 36% |
1 Year: | 36% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 25% |
3 Years: | 23% |
Last Year: | 22% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|
5 | 5 | 5 | 80 | 81 | 83 | 83 | 83 | 83 | 83 | 83 | |
Reserves | 88 | 111 | 157 | 151 | 260 | 424 | 512 | 734 | 890 | 974 | 1,073 |
Borrowings | 20 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
59 | 63 | 108 | 146 | 161 | 119 | 95 | 98 | 117 | 317 | 360 | |
Total Liabilities | 169 | 177 | 269 | 352 | 475 | 625 | 690 | 916 | 1,091 | 1,374 | 1,517 |
112 | 108 | 127 | 140 | 150 | 166 | 152 | 208 | 209 | 413 | 417 | |
CWIP | 0 | 6 | 1 | 0 | 1 | 4 | 18 | 10 | 3 | 11 | 4 |
Investments | 1 | 5 | 55 | 9 | 38 | 64 | 106 | 145 | 185 | 164 | 122 |
56 | 58 | 87 | 203 | 286 | 391 | 414 | 554 | 694 | 786 | 974 | |
Total Assets | 169 | 177 | 269 | 352 | 475 | 625 | 690 | 916 | 1,091 | 1,374 | 1,517 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
42 | 68 | 88 | 98 | 122 | 159 | 171 | 197 | 219 | 284 | |
-19 | -26 | -64 | -89 | -113 | -163 | -137 | -172 | -100 | -26 | |
-22 | -38 | -15 | -10 | -1 | 0 | -32 | 13 | -55 | -190 | |
Net Cash Flow | 1 | 4 | 9 | -2 | 8 | -5 | 2 | 37 | 64 | 67 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
ROCE % | 60% | 58% | 61% | 49% | 47% | 43% | 37% | 34% | 32% | |
Debtor Days | 15 | 15 | 16 | 16 | 17 | 17 | 17 | 14 | 16 | 14 |
Inventory Turnover | 0.76 | 1.01 | 0.95 | 11.60 | 12.90 | 12.99 | 10.67 | 9.95 | 7.38 |
Documents
Add documentRecent announcements
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 2d
- Announcement under Regulation 30 (LODR)-Newspaper Publication 19 Jan
- Board to consider Q3 results & Second Interim Dividend on Jan 29, 2021 18 Jan
- Board Meeting Intimation for Notice Of Board Meeting 18 Jan
- Shareholding for the Period Ended December 31, 2020 12 Jan
View all